Press room | News



Sep 16, 2014

Heptares To Present On Structure-based Drug Design Using G Protein-coupled Reception At Inaugural Chemistry & Engineering News Virtual Symposium

Sep 10, 2014

Heptares to present at CNS Partnering & Deal-Making and Biopharm America

Jul 7, 2014

Heptares Announces Publication In Nature Of First Structure Of Metabotropic Glutamate Receptor 5 Transmembrane Domain

Jun 30, 2014

Heptares Chief Scientific Officer And Co-founder Fiona Marshall to Present At Royal Society Of Medicine Medical Innovations Summit

Jun 24, 2014

Heptares To Present At JMP Securities Healthcare Conference

May 29, 2014

Heptares To Present At Jefferies 2014 Global Healthcare Conference And Upcoming Industry And Scientific Events

May 15, 2014

Heptares To Present At UBS Global Healthcare Conference And Upcoming Scientific Events

Apr 16, 2014

Heptares At Upcoming Diabetes And Neuroscience Partnering And Investment Conferences

Mar 26, 2014

Heptares Presentation at Future Leaders in the Biotech Industry to be Webcast

Mar 7, 2014

Heptares To Present At Upcoming Biotech Business Development Events

Jan 23, 2014

Heptares Successfully Completes Research Phase Of Antibody Discovery Collaboration With MedImmune

Jan 9, 2014

Heptares Appoints Tim Tasker As Chief Medical Officer

Jan 8, 2014

Heptares To Moderate Panel On Global Business Development At Upcoming Boston Biotech East/West CEO Conference

Dec 16, 2013

Heptares Hightlights Potential Of Star® Proteins As Antigens For GPCR-Targeted Antibody Discovery In New Scientific Publication

Dec 9, 2013

Heptares Initiates Clinical Study With First Selective Muscarinic M1 Receptor Agonist For Improving Cognition In Patients With Alzheimer’s Disease

Oct 10, 2013

Heptares Delivers First Stabilised GPCR (StaR®) To Morphosys For Antibody Discovery

Sep 6, 2013

Heptares To Present At Upcoming Scientific And Biotech Industry Conferences

Jul 22, 2013

Heptares Achieves First Research Milestone In Research Collaboration With Cubist

Jul 17, 2013

Heptares Announces Publication In Nature Of Class B GPCR Structure

Jun 27, 2013

Heptares Raises US$21 Million To Advance Novel GPCR Medicines Into Clinical Development

Jun 6, 2013

Heptares To Present At Upcoming Biotech Industry Conferences

May 24, 2013

Heptares Augments Business Development Capabilities In Japan And Other Asian Territories

Apr 29, 2013

Heptares Achieves All Research Milestones And Receives Milestone Payment From GPCR Drug Discovery Agreement With Takeda

Apr 16, 2013

Heptares To Present At Upcoming Scientific And Biotech Industry Conferences

Apr 2, 2013

Heptares To Present At Boston Biotech BD And Future Leaders In The Biotech Industry Conferences

Mar 18, 2013

Heptares StaRs® Enable ‘Reverse Pharmacology’ Approach To Accelerate GPCR-Focused Drug Discovery

Mar 1, 2013
Heptares To Present At The 6th Annual European Life Sciences CEO Forum (5-6 March)

Feb 13, 2013

MorphoSys And Heptares Sign Alliance To Develop Antibody Therapeutics Targeting GPCRs

Feb 8, 2013

Heptares To Moderate Panel On Rare Diseases At BBC New York CEO meeting (13-14 February)

Jan 7, 2013

Heptares Partners With Cubist To Research New Medicines Targeting GPCRs

Back to top

Other News


© 2012-2014 Heptares Therapeutics